Search

everythinglearnresearchcommunity

for

Search:↓

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Mice without certain skin enzymes have faster hair growth and bigger eye glands.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Plant extracts can help prevent hair loss and promote hair growth.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Extracts from three Polynesian plants were found to promote hair growth by affecting cell growth and gene expression related to hair.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

There are two ways to start hair growth: one needs Stat3 and the other does not, but both need PI3K activation.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

Type XVII collagen helps control skin cell growth and could be a target for anti-aging treatments.

Bitter melon extract may help prevent hair loss and can be used in cosmetic products.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.